First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

Alzheimer's and Dementia

Volumn 10, Issue 1 SUPPL., 2014, Pages

  Hölscher, Christian ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Clinical trial; Cxidative stress; Growth factors; Neurodegeneration

Indexed keywords

INSULIN;

ALZHEIMER DISEASE; CLINICAL STUDY; COGNITION; DRUG DEVELOPMENT; DRUG MECHANISM; HUMAN; INSULIN TREATMENT; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

CLINICAL TRIAL; CXIDATIVE STRESS; GROWTH FACTORS; NEURODEGENERATION;

ADMINISTRATION, INTRANASAL; ALZHEIMER DISEASE; ANIMALS; HUMANS; INSULIN; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTIVE AGENTS;

EID: 84897872830     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.12.006     Document Type: Review

References (40)

1. F. Trudeau, S. Gagnon, and G. Massicotte Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus Eur J Pharmacol 490 2004 177 186
2. G.J. Biessels, F.E. De Leeuw, J. Lindeboom, F. Barkhof, and P. Scheltens Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus J Neurol Neurosurg Psychiatry 77 2006 304 307
3. U. Stockhorst, D. de Fries, H.J. Steingrueber, and W.A. Scherbaum Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans Physiol Behav 83 2004 47 54
4. W.H. Gispen, and G.J. Biessels Cognition and synaptic plasticity in diabetes mellitus Trends Neurosci 23 2000 542 549
5. G.J. Biessels, B. Bravenboer, and W.H. Gispen Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface Eur J Pharmacol 490 2004 1 4
6. D.W. Porter, B.D. Kerr, P.R. Flatt, C. Hölscher, and V.A. Gault Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice Eur J Pharmacol 650 2010 688 693
7. D.W. Porter, B.D. Kerr, P.R. Flatt, C. Hölscher, and V.A. Gault Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance Diabetes Obes Metab 12 2010 891 899
8. S. Hoyer Glucose metabolism and insulin receptor signal transduction in Alzheimer disease Eur J Pharmacol 490 2004 115 125
9. E. Carro, and I. Torres-Aleman Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects? Expert Rev Neurother 4 2004 79 86
10. A.M. Moloney, R.J. Griffin, S. Timmons, R. O'Connor, R. Ravid, and C. O'Neill Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signaling Neurobiol Aging 31 2010 224 243
11. K. Talbot, H.Y. Wang, H. Kazi, L.Y. Han, K.P. Bakshi, and A. Stucky Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 122 2012 1316 1338
12. T.R. Bomfim, L. Forny-Germano, L.B. Sathler, J. Brito-Moreira, J.C. Houzel, and H. Decker An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers J Clin Invest 122 2012 1339 1353
13. C. Hölscher Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies Rev Neurosci 16 2005 181 212
14. L. Li, and C. Hölscher Common pathological processes in Alzheimer disease and type 2 diabetes: a review Brain Res Rev 56 2007 384 402
15. A. Cohen, M. Tong, J. Wands, and Monte S. de la Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model Alcohol Clin Exp Res 31 2007 1558 1573
16. P. van Dam, and A. Aleman Insulin-like growth factor-I, cognition and brain aging Eur J Pharmacol 490 2004 87 95
17. E. Carro, and A.I. Torres The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease Eur J Pharmacol 490 2004 127 133
18. G.S. Watson, and S. Craft Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease Eur J Pharmacol 490 2004 97 113
19. W.Q. Zhao, H. Chen, M.J. Quon, and D.L. Alkon Insulin and the insulin receptor in experimental models of learning and memory Eur J Pharmacol 490 2004 71 81
20. M.A. Reger, G.S. Watson, P.S. Green, L.D. Baker, B. Cholerton, and M.A. Fishel et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults J Alzheimers Dis 13 2008 323 331
21. O.I. Okereke, D.J. Selkoe, M.N. Pollak, M.J. Stampfer, F.B. Hu, and S.E. Hankinson et al. A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation Int J Geriatr Psychiatry 24 2008 177 182
22. J. Born, T. Lange, W. Kern, G.P. McGregor, U. Bickel, and H.L. Fehm Sniffing neuropeptides: a transnasal approach to the human brain Nat Neurosci 5 2002 514 516
23. G.D. Baura, D.M. Foster, D. Porte Jr, S.E. Kahn, R.N. Bergman, and C. Cobelli et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain J Clin Invest 92 1993 1824 1830
24. M. Hallschmid, B. Schultes, L. Marshall, M. Molle, W. Kern, and J. Bredthauer et al. Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain Diabetes 53 2004 2202 2208
25. C. Benedict, M. Hallschmid, A. Hatke, B. Schultes, H.L. Fehm, and J. Born et al. Intranasal insulin improves memory in humans Psychoneuroendocrinology 29 2004 1326 1334
26. C. Benedict, M. Hallschmid, K. Schmitz, B. Schultes, F. Ratter, and H.L. Fehm et al. Intranasal insulin improves memory in humans: superiority of insulin aspart Neuropsychopharmacology 32 2007 239 243
27. R. Krug, C. Benedict, J. Born, and M. Hallschmid Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory J Clin Endocrinol Metab 95 2010 E468 E472
28. C. Benedict, W. Kern, B. Schultes, J. Born, and M. Hallschmid Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin J Clin Endocrinol Metab 93 2008 1339 1344
29. M.A. Reger, G.S. Watson, W.H. Frey 2nd, L.D. Baker, B. Cholerton, and M.L. Keeling et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiol Aging 27 2006 451 458
30. M.A. Reger, G.S. Watson, P.S. Green, C.W. Wilkinson, L.D. Baker, and B. Cholerton et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 70 2008 440 448
31. S. Craft, L.D. Baker, T.J. Montine, S. Minoshima, G.S. Watson, and A. Claxton et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial Arch Neurol 69 2012 29 38
32. Craft S. Therapeutic effects of long-acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment. Presented as an abstract at the AAIC Conference, Boston, MA. July 13-18, 2013.
33. G.E. Dailey Using prandial insulin to achieve glycemic control in type 2 diabetes J Fam Pract 56 2007 735 742
34. A. Lund, T. Vilsboll, J.I. Bagger, J.J. Holst, and F.K. Knop The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes Am J Physiol Endocrinol Metab 300 2011 E1038 E1046
35. J.E. Campbell, and D.J. Drucker Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab 17 2013 819 837
36. S. Madsbad, U. Kielgast, M. Asmar, C.F. Deacon, S.S. Torekov, and J.J. Holst An overview of once-weekly glucagon-like peptide-1 receptor agonists: available efficacy and safety data and perspectives for the future Diabetes Obes Metab 13 2011 394 407
37. T. Wadden, P. Hollander, S. Klein, K. Niswender, V. Woo, and P.M. Hale et al. Weight maintenance and additional weight loss with liraglutide after low-calorie diet-induced weight loss: the SCALE Maintenance randomized study Int J Obes (Lond) 2013
38. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF). Available at: http://clinicaltrials.gov/ct2/show/NCT01767909?term= insulin+AND+Alzheimer&rank=1. Accessed February 2, 2014.
39. Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease. Available at: http://clinicaltrials.gov/ct2/ show/NCT01636596?term=insulin+AND+Alzheimer&rank=3. Accessed February 2, 2014.
40. Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. Available at: http:// clinicaltrials.gov/ct2/show/NCT01436045?term=insulin+AND+Alzheimer&rank=4. Accessed February 2, 2014.